Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation - Sign of tumour cell revertance?

European Journal of Cancer

Volumn 33, Issue 12, 1997, Pages 2043-2049

  Ambros, I M ^a   Rumpler, S ^a   Luegmayr, A ^a   Hattinger, C M ^a   Strehl, S ^a   Kovar, H ^a   Gadner, H ^a   Ambros, P F ^a  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

Cell lines; F cells; in situ hybridisation; MHC I; Micronuclei; MYCN amplification; MYCN expression; N cells; Neuroblastoma; Proliferative activity; Revertant cells

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

CELL DIFFERENTIATION; CHILDHOOD CANCER; CONFERENCE PAPER; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR CELL LINE;

CELL DIVISION; GENE AMPLIFICATION; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; NEOPLASM PROTEINS; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0031409773     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00204-9     Document Type: Conference Paper

References (47)

1. Ambros IM, Zellner A, Roald B, et al. Role of ploidy, chromosome 1p integrity and Schwann cells for maturation in neuroblastoma. NEJM 1996, 334, 1505-1511.
2. Brodeur G. M., Seeger R. C., Schwab M., Varmus H. E., Bishop J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 224:1984;1121-1124.
3. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313, 1111-1116.
4. Stanton B. R., Parada L. F. The N-myc proto-oncogene: developmental expression and in vivo site-directed mutagenesis. Brain Pathol. 2:1992;71-83.
5. Schwab M, Alitalo K, Klempnauer K-H, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 1983, 305, 245-248.
6. Schwab M., Varmus H. E., Bishop J. M. Chromosomal localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature. 308:1984;288-291.
7. Ramsey T., Stanton L., Schwab M., Bishop J. M. Human proto-oncogene N-myc encodes a nuclear protein that binds DNA. Mol Cell Biol. 6:1987;4450-4457.
8. Tumilowicz J. J., Nichols W. W., Cholon J. J., Greene A. E. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res. 30:1970;2110-2118.
9. Biedler J. H., Helson L., Spengler B. A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:1973;2643-2652.
10. Ross R. A., Spengler B. A., Biedler J. H. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst. 71:1983;741-747.
11. Ross R. A., Biedler J. L. Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro. Cancer Res. 45:1985;1628-1632.
12. Sidell N., Saraffian T., Kelly M., Tsuchida T., Haussler M. R. Retinoic acid-induced differentiation of human neuroblastoma: a cell variant system showing two distinct responses. Exp Cell Biol. 54:1986;287-300.
13. Tsokos M., Scarpa S., Ross R. A., Triche T. J. Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins. Am J Pathol. 128:(3):1987;484-496.
14. Reynolds CP, Perez-Polo. Induction of neurite outgrowth in the IMR-32 human neuroblastoma cell line by nerve growth factor. J Neurosci Res 1981, 6, 319-325.
15. Sidell N., Altman A., Haussler M. R., Seeger R. C. Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp Cell Res. 148:1983;21-30.
16. Tsunamoto K., Todo S., Imashuku S., Kato K. Induction of S 100 protein by 5-bromo-2′-deoxyuridine in human neuroblastoma cell lines. Cancer Res. 48:1988;170-174.
17. Pahlman S., Odelstad L., Larsson E., Grotte G., Nilsson K. Phenotypic changes of human neuroblastoma cell in culture induced by 12-0-tetradecanoyl-phorbol-12-acetate. Int J Cancer. 28:1981;583-589.
18. Ross RA, Ciccarone V, Meyers MB, Spengler BA, Biedler JL. Differential expression of intermediate filaments and fibronectin in human neuroblastoma cells. In Evans AE, D'Angio GJ, Knudson GA, Seeger RC, eds. Advances in Neuroblastoma Research, 2nd edn. New York, Wiley-Liss Inc., 1987, 277-289.
19. Rettig W. J., Spengler B. A., Garin Chesa P., Old L. J., Piedler J. L. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res. 47:1987;1383-1389.
20. Ciccarone V., Spengler B. A., Meyers M. B., Biedler J. L., Ross R. A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 49:1989;219-225.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. New York, Cold Spring Harbor Laboratory Press, 1989.
22. Lichter P., Chang Tang C.-J., Call K., et al. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science. 247:1990;64-69.
23. Stock C, Ambros IM, Lion T, et al. Detection of numeric and structural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics. Genes Chrom Cancer 1994, 11, 40-50.
24. Wenzel A., Cziepluch C., Hamann U., Schurmann J., Schwab M. The N-myc oncoprotein is associated in vivo with the phophoprotein Max (p20/22) in human neuroblastoma cells. EMBO J. 10:(12):1991;3703-3712.
25. Weissenborn U., Streffer C. Micronuclei with kinetochores in human melanoma cells and rectal carcinomas. Int J Radiat Biol. 59:(2):1991;373-378.
26. Belien J. A., Cooper M. P., Braakhuis B. J., Snow G. B., Baak J. P. Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells. Carcinogenesis. 16:(10):1995;2395-2400.
27. Guttenbach M., Schakowski R., Schmid M. Aneuploidy and ageing: sex chromosome exclusion into micronuclei. Hum Genet. 94:(3):1994;295-298.
28. Miller B. M., Nusse M. Analysis of micronuclei induced by 2-chlorobenzylidene malonitrile (CS) using fluorescence in situ hybridization with telomeric and centromeric DNA probes, and flow cytometry. Mutagenesis. 8:(1):1993;35-41.
29. Miller B. M., Werner T., Weier H. U., Nusse M. Analysis of radiation induced micronuclei by fluorescence in situ hybridization (FISH) simultaneously using telomeric and centromeric DNA probes. Radiat Res. 131:(2):1992;177-185.
30. Von Hoff DD, Mc Gill JR, Forseth BJ, et al. Elimination of extrachromosomally amplified MYC genes from human tumor cell reduces their tumorigenicity. Proc Natl Acad Sci USA 1992, 89, 8165-8169.
31. Sugio K., Nakagawara A., Sasazuki T. Association of expression between N-myc and major histocompatibility complex class I gene in surgically resected human neuroblastoma. Cancer. 67:(5):1991;1384-1388.
32. Versteeg R., Van der Minne C., Plomp A., et al. N-myc expression switched off and class I human leukocyte antigen expression switched on after somatic cell fusion of neuroblastoma cells. Mol Cell Biol. 10:(10):1990;5416-5423.
33. Biedler JL, Spengler BA, Chang T, Ross RA. Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. In Evans AE, D'Angio GJ, Knudson GA, Seeger RC, eds. Advances in Neuroblastoma Research, 2nd edn., New York, Wiley-Liss Inc., 1987, 265-276.
34. Foley J, Cohn SL, Salwen HR, et al. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res 1991, 51, 6338-6345.
35. Yang Q., Hamberger A., Hyden H., Wang S., Stigbrand T., Haglid K. G. S-100 beta has a neuronal localisation in the rat hindbrain revealed by an antigen retrieval method. Brain Res. 696:(1):1995;49-61.
36. Pribyl TM, Campagnoni CW, Kampf K, et al. The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. Proc Natl Acad Sci USA 1993, 90(22), 10695-10699.
37. Kawamoto S, Inoue Y, Shinozaki Y, et al. Impaired tumor phenotypes in class II major histocompatibility complex antigen-inducible cells originated from human lung carcinoma. Biochem Biophys Res Commun 1995, 215(1), 280-285.
38. Ohizumi I., Tanemura M., Kaihoh S. A novel styryl diphenylamine derivative reverts the transformed phenotype of human fibrosarcoma HT1080 cells. Br J Cancer. 72:(5):1995;1219-1223.
39. Andersen J. K., Zhang M. B., Zhong X. H., Rozenberg Y. Y., Howard B. D. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridin-resistant, flat cell PC12 variants having a partial loss of transformed phenotype. J Neurochem. 52:(2):1990;559-567.
40. Kodama K., Doi O., Higashiyama M., Yokouchi H., Tateishi R., Mori Y. Differentiation of a Ewing's sarcoma cell line towards neural and mesenchymal cell lineages. Jpn J Cancer Res. 85:(4):1994;335-338.
41. Oka T., Yutsudo M., Inoue H., Higuchi F., Hakura A. Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab-MuLV). J Cell Physiol. 145:(3):1990;428-433.
42. Nakanishi K, Yong IH, Ishiwatari H, et al. Isolation of flat revertants from human papillomavirus type 18 E6E7 transformed 3Y1 cells by transfection with a rat embryo fibroblast cDNA expression library. Cell Struct Funct 1993, 18(6), 457-465.
43. Kolch W., Heidecker G., Troppmair J., et al. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum. Oncogene. 8:(2):1993;361-370.
44. Krzyzosiak W. J., Shindo-Okada N., Teshima H., Nakajima K., Nishimura S. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine. Proc Natl Acad Sci USA. 89:(11):1992;4879-4883.
45. Jenkins DC, Stables JN, Wilkinson J, et al. A novel cell-based assay for the evaluation of anti-ras compounds. Br J Cancer 1993, 68(5), 856-861.
46. Ross R. A., Spengler B. A., Doménech C., et al. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differentiation. 6:1995;449-456.
47. Ross R. A., Spengler B. A., Rettig W. J., Biedler J. L. Differentiation inducing agents stably convert human neuroblastoma I-type cells to neuroblastic (N) or nonneural (S) neural crest cells. Prog Clin Biol Res. 385:1994;253-259.